First Trust Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $16.1M | Buy |
|
|||||
|
2024
Q2 | $772K | Sell |
|
|||||
|
2024
Q1 | $7.62M | Sell |
|
|||||
|
2023
Q4 | $55.5M | Sell |
|
|||||
|
2023
Q3 | $51.5M | Sell |
|
|||||
|
2023
Q2 | $54.3M | Sell |
|
|||||
|
2023
Q1 | $58.6M | Sell |
|
|||||
|
2022
Q4 | $67.3M | Sell |
|
|||||
|
2022
Q3 | $91.9M | Buy |
|
|||||
|
2022
Q2 | $59.1M | Sell |
|
|||||
|
2022
Q1 | $59.9M | Sell |
|
|||||
|
2021
Q4 | $51.1M | Sell |
|
|||||
|
2021
Q3 | $56.4M | Buy |
|
|||||
|
2021
Q2 | $60.7M | Buy |
|
|||||
|
2021
Q1 | $52.5M | Sell |
|
|||||
|
2020
Q4 | $78.4M | Sell |
|
|||||
|
2020
Q3 | $66.3M | Buy |
|
|||||
|
2020
Q2 | $77.5M | Buy |
|
|||||
|
2020
Q1 | $45M | Sell |
|
|||||
|
2019
Q4 | $60.4M | Buy |
|
|||||
|
2019
Q3 | $59.2M | Sell |
|
|||||
|
2019
Q2 | $109M | Sell |
|
|||||
|
2019
Q1 | $210M | Buy |
|
|||||
|
2018
Q4 | $120M | Buy |
|
|||||
|
2018
Q3 | $110M | Buy |
|
|||||
|
2018
Q2 | $44.5M | Buy |
|
|||||
|
2018
Q1 | $45.3M | Buy |
|
|||||
|
2017
Q4 | $46.9M | Sell |
|
|||||
|
2017
Q3 | $49.8M | Buy |
|
|||||
|
2017
Q2 | $35.6M | Buy |
|
|||||
|
2017
Q1 | $27M | Sell |
|
|||||
|
2016
Q4 | $45.4M | Sell |
|
|||||
|
2016
Q3 | $36.5M | Buy |
|
|||||
|
2016
Q2 | $15.7M | Sell |
|
|||||
|
2016
Q1 | $44.2M | Sell |
|
|||||
|
2015
Q4 | $144M | Buy |
|
|||||
|
2015
Q3 | $91M | Buy |
|
|||||
|
2015
Q2 | $102M | Buy |
|
|||||
|
2015
Q1 | $88.2M | Sell |
|
|||||
|
2014
Q4 | $96.3M | Buy |
|